Study has major shortcomingsBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3704 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3704
- Fritz H Schroder, urologist1
- 1Erasmus Medical Centre, Rotterdam, Netherlands
Although Sandblom and colleagues’ study is the longest follow-up to date of prostate cancer screening,1 it has some major shortcomings.
(1) The group of men randomised to screening is small. Of the 1494 men, only 1161 participated in the initial screening (78%). Those who refused are apparently …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial